University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more ...

Aortic aneurysms — dangerous bulges in the body’s main artery, the aorta — are becoming increasingly common as more people ...

The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

Aortic stenosis is a narrowing of the aortic valve opening, which restricts blood flow from the heart to the rest of the body ...

The FDA approved Edwards Lifesciences Corp.'s Sapien 3 platform for patients with asymptomatic severe aortic stenosis.

The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Current risk assessment guidelines for ischemic stroke may underestimate patients with mild carotid stenosis. A Japanese ...

Intracranial FF is also a valuable hemodynamic index to assess the severity of narrowing in intracranial atherosclerotic stenosis (ICAS). This study aims to investigate the predictive value of FF in ...

These are called “degrees.” You can have a first-, second-, third-, or fourth-degree burn. The higher the degree, the more severe the burn is. First-degree. These burns only affect the outer ...